Bioinformatics gears up for 2013

India will see renewed interest in high-throughput technology with increasing focus on genomics and proteomics that augers well for bioinformatics


India has immense opportunities in the area of BioIT

What we will see in 2013 is that computing, algorithms, and mathematics are being used as microscopes; mining through gigabytes of omic data. Using these technologies we will proceed towards predictable medicine, precision agriculture, high yield crops, and economic biofuel much faster. As a company, Geschickten Biosciences is already designing computer algorithms for cancer research and disease resistant crops. In early 2013, we expect to start working on immunogenetics, pharmacogenomics and biofuels. We have invested substantially in pharmacogenetics and personalized medicine techniques, which we expect will give us returns by end of 2013. We also plan to integrate a flavor of mathematics with computational genetics to develop a technique called "DNA Signal Processing", which we believe will help revolutionize the understanding of the information content in a DNA for better disease management.

- Dr Asoke K Talukder, chief scientific officer, Geschickten Biosciences

We can see a tremendous growth in pharmaceutical sector as many of blockbuster molecules expired in 2011-12 and pharmaceutical industry is again gearing up to discover new molecules as well as collaborating with small and medium size R&D partners for fastening the discovery process.

As far as 2013 is concerned, we are initiating our own R&D projects from January 2013 for discovering lead molecules. We are planning to diversify our business in cosmetology, food and agriculture sector soon by partnering with prominent players in these sectors. We are hoping to show success in 2013 with new molecules in market.

- Mr Sahil Kapoor, director and cofounder, head, Global Business Operations, Novo Informatics

Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email